ALNY · Alnylam Pharmaceuticals, Inc.
$228.65
+1.53 (+0.67%)
At close · Aug 14
Market Cap
$30.60B
Shares
133.81M
Private capital raises reported to the SEC on Form D under Regulation D, showing the offering size, amount sold, minimum investment and number of investors. Public operating companies rarely raise capital this way, so this page is often empty.
No Exempt Offerings
No Form D exempt-offering notices are available for this stock yet.
Key facts
CIK
1178670
CUSIP
02043Q107
13F (30d)
739 filings
705 filers
Visit website
Investor relations